The Lorad division of Hologic and Ethicon Endo-Surgery have struck a nonexclusive distribution agreement for Ethicon’s minimally invasive breast biopsy system, the Mammotome ST. Under terms of the agreement, which pertains only to the U.S., Hologic
The Lorad division of Hologic and Ethicon Endo-Surgery have struck a nonexclusive distribution agreement for Ethicon’s minimally invasive breast biopsy system, the Mammotome ST. Under terms of the agreement, which pertains only to the U.S., Hologic may offer the Mammotome ST for purchase with Lorad’s MultiCare and StereoLoc II stereotactic breast biopsy systems. The Mammotome ST is complementary to and compatible with Lorad’s two breast biopsy systems, which use digital imaging to pinpoint the location of suspicious lesions. The Mammotome ST can be used to obtain multiple tissue samples through a single, relatively small incision in the skin, using only local anesthesia. Open surgical biopsy removes a large section of tissue through a 1 to 3-inch incision, often under general anesthesia.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.